Gyre Therapeutics, Inc. Public Float
Gyre Therapeutics, Inc. (GYRE) had Public Float of $72.60 million as of 2025-06-30, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $72.60M.
- 2024-06-30: Entity Public Float $83.30M.
- 2023-06-30: Entity Public Float $11.10M.
- 2022-06-30: Entity Public Float $55.64M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $72.60M 10-K · filed 2026-03-13 |
| 2024-06-30 | $83.30M 10-K · filed 2025-03-17 |
| 2023-06-30 | $11.10M 10-K · filed 2024-03-27 |
| 2022-06-30 | $55.64M 10-K · filed 2023-03-30 |
| 2021-06-30 | $135.05M 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $128.36M 10-K · filed 2021-03-04 |
| 2019-06-30 | $86.98M 10-K · filed 2020-02-20 |
| 2018-06-30 | $137.45M 10-K · filed 2019-03-08 |
| 2017-06-30 | $22.44M 10-K · filed 2018-03-19 |
| 2016-06-30 | $12.08M 10-K · filed 2017-03-08 |
| 2015-06-30 | $63.20M 10-K · filed 2016-03-09 |
| 2014-06-30 | $101.56M 10-K · filed 2015-03-16 |
| 2013-06-30 | $97.53M 10-K · filed 2014-03-14 |
| 2012-06-30 | $123.87M 10-K · filed 2013-03-15 |
| 2011-06-30 | $606.11M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |